A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
about
Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles.Cannabinoid signaling in health and disease.Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the endocannabinoid system in white and brown adipose tissue of weanling rat offspring.The current state of GPCR-based drug discovery to treat metabolic disease.Role of Cannabinoids in Obesity
P2860
A novel peripheral cannabinoid receptor 1 antagonist, BPR0912, reduces weight independently of food intake and modulates thermogenesis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
A novel peripheral cannabinoid ...... e and modulates thermogenesis.
@en
A novel peripheral cannabinoid ...... e and modulates thermogenesis.
@nl
type
label
A novel peripheral cannabinoid ...... e and modulates thermogenesis.
@en
A novel peripheral cannabinoid ...... e and modulates thermogenesis.
@nl
prefLabel
A novel peripheral cannabinoid ...... e and modulates thermogenesis.
@en
A novel peripheral cannabinoid ...... e and modulates thermogenesis.
@nl
P2093
P2860
P921
P356
P1476
A novel peripheral cannabinoid ...... e and modulates thermogenesis.
@en
P2093
P2860
P304
P356
10.1111/DOM.12447
P577
2015-02-25T00:00:00Z